Switch to:

CRISPR Therapeutics AG Revenue per Share

: $4.82 (TTM As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

CRISPR Therapeutics AG's revenue per share for the three months ended in Jun. 2020 was $0.00. CRISPR Therapeutics AG's revenue per share for the trailing twelve months (TTM) ended in Jun. 2020 was $4.82.

During the past 12 months, the average Revenue Per Share Growth Rate of CRISPR Therapeutics AG was 18446.20% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 129.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

NAS:CRSP' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 101   Med: 115.25   Max: 129.5
Current: 129.5

101
129.5

During the past 6 years, CRISPR Therapeutics AG's highest 3-Year average Revenue Per Share Growth Rate was 129.50% per year. The lowest was 101.00% per year. And the median was 115.25% per year.

NAS:CRSP's 3-Year Revenue Growth Rate is ranked higher than
95% of the 713 Companies
in the Biotechnology industry.

( Industry Median: 2.30 vs. NAS:CRSP: 129.50 )

CRISPR Therapeutics AG Revenue per Share Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Revenue per Share Premium Member Only 0.01 0.42 1.02 0.07 5.09

CRISPR Therapeutics AG Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Revenue per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 1.14 0.00 0.00 0.00

CRISPR Therapeutics AG Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

CRISPR Therapeutics AG's Revenue Per Share for the fiscal year that ended in Dec. 2019 is calculated as

Revenue Per Share (A: Dec. 2019 )=Revenue (A: Dec. 2019 )/Shares Outstanding (Diluted Average) (A: Dec. 2019 )
=289.59/56.933
=5.09

CRISPR Therapeutics AG's Revenue Per Share for the quarter that ended in Jun. 2020 is calculated as

Revenue Per Share (Q: {Q1})=Revenue (Q: Jun. 2020 )/Shares Outstanding (Diluted Average) (Q: Jun. 2020 )
=0.044/61.421
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 3.679 (Sep. 2019 ) + 1.139 (Dec. 2019 ) + 0.003 (Mar. 2020 ) + 0.001 (Jun. 2020 ) = $4.82

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG  (NAS:CRSP) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


CRISPR Therapeutics AG Revenue per Share Related Terms


CRISPR Therapeutics AG Revenue per Share Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)